This inventor holds 1 USPTO granted patent. Top assignee: Eli Lilly and Company. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Adel Ahmed - Innovator in cGAS Inhibitors
Introduction
Adel Ahmed is a notable inventor based in Fishers, Indiana, who has made significant contributions to the field of pharmaceutical sciences. His work primarily focuses on developing novel compounds that can inhibit cGAS, a key player in immune responses.
Latest Patents
Adel Ahmed holds 1 patent related to cGAS inhibitors. This patent encompasses innovative compounds designed to treat various immune-mediated diseases. The invention details pharmaceutical compositions that utilize these compounds, showcasing their potential in addressing significant pathological conditions.
Career Highlights
Adel is currently employed at Eli Lilly and Company, a leading global pharmaceutical company known for its commitment to innovation and improving patient outcomes. His role involves extensive research and development, contributing to the advancement of therapeutic solutions.
Collaborations
Adel collaborates with talented colleagues, including Emmanuel Onobun and Thibault Francois Varin. Their combined expertise fosters a dynamic research environment, enhancing the potential for groundbreaking discoveries in the pharmaceutical field.
Conclusion
Adel Ahmed's work in developing cGAS inhibitors represents a significant advancement in treating immune-mediated diseases. His contributions at Eli Lilly and Company highlight the importance of innovation in the pharmaceutical industry.